These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35721932)

  • 1. Oral Bioavailability-Enhancing and Anti-obesity Effects of Hydroxysafflor Yellow A in Natural Deep Eutectic Solvent.
    Gao H; Zhou HM; Yue SJ; Feng LM; Guo DY; Li JJ; Zhao Q; Huang L; Tang YP
    ACS Omega; 2022 Jun; 7(23):19225-19234. PubMed ID: 35721932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism.
    Liu J; Yue S; Yang Z; Feng W; Meng X; Wang A; Peng C; Wang C; Yan D
    Pharmacol Res; 2018 Aug; 134():40-50. PubMed ID: 29787870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intragastric safflower yellow and its main component HSYA improve leptin sensitivity before body weight change in diet-induced obese mice.
    Lyu X; Yan K; Xu H; Zhu H; Pan H; Wang L; Yang H; Gong F
    Naunyn Schmiedebergs Arch Pharmacol; 2022 May; 395(5):579-591. PubMed ID: 35201390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safflower Yellow and Its Main Component HSYA Alleviate Diet-Induced Obesity in Mice: Possible Involvement of the Increased Antioxidant Enzymes in Liver and Adipose Tissue.
    Yan K; Wang X; Pan H; Wang L; Yang H; Liu M; Zhu H; Gong F
    Front Pharmacol; 2020; 11():482. PubMed ID: 32372961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A.
    Zhao B; Gu S; Du Y; Shen M; Liu X; Shen Y
    Int J Pharm; 2018 Jan; 535(1-2):164-171. PubMed ID: 29107614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetic effect of Sappan Lignum on hydroxysafflor yellow A in Carthami Flos].
    Xia L; Chen XM; Peng LR; Wang SX; Wang XW; Zuo Y; Zhang P; Liu QS; Zheng XH
    Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(2):269-72. PubMed ID: 23672054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safflower yellow and its main component hydroxysafflor yellow A alleviate hyperleptinemia in diet-induced obesity mice through a dual inhibition of the GIP-GIPR signaling axis.
    Lyu X; Yan K; Hu W; Xu H; Guo X; Zhou Z; Zhu H; Pan H; Wang L; Yang H; Gong F
    Phytother Res; 2023 Mar; ():. PubMed ID: 36943416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Analysis of the Effects of Hydroxysafflor Yellow A and Anhydrosafflor Yellow B in Safflower Series of Herb Pairs Using Prep-HPLC and a Selective Knock-Out Approach.
    Qu C; Wang LY; Jin WT; Tang YP; Jin Y; Shi XQ; Shang LL; Shang EX; Duan JA
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27827969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel oral preparation of hydroxysafflor yellow A base on a chitosan complex: a strategy to enhance the oral bioavailability.
    Ma GN; Yu FL; Wang S; Li ZP; Xie XY; Mei XG
    AAPS PharmSciTech; 2015 Jun; 16(3):675-82. PubMed ID: 25511808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing effect of Labrafac Lipophile WL 1349 on oral bioavailability of hydroxysafflor yellow A in rats.
    Wang S; Sun M; Ping Q
    Int J Pharm; 2008 Jun; 358(1-2):198-204. PubMed ID: 18417306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury
    Ye J; Lu S; Wang M; Ge W; Liu H; Qi Y; Fu J; Zhang Q; Zhang B; Sun G; Sun X
    Front Pharmacol; 2020; 11():1170. PubMed ID: 32848777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Hydroxysafflor Yellow A on the PI3K/AKT Pathway and Apoptosis of Pancreatic β-Cells in Type 2 Diabetes Mellitus Rats.
    Lee M; Li H; Zhao H; Suo M; Liu D
    Diabetes Metab Syndr Obes; 2020; 13():1097-1107. PubMed ID: 32308459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greener extraction process and enhanced in vivo bioavailability of bioactive components from Carthamus tinctorius L. by natural deep eutectic solvents.
    Tong X; Yang J; Zhao Y; Wan H; He Y; Zhang L; Wan H; Li C
    Food Chem; 2021 Jun; 348():129090. PubMed ID: 33524695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective Effect of Hydroxysafflor Yellow A on Nephropathy by Attenuating Oxidative Stress and Inhibiting Apoptosis in Induced Type 2 Diabetes in Rat.
    Lee M; Zhao H; Liu X; Liu D; Chen J; Li Z; Chu S; Kou X; Liao S; Deng Y; Li H; Xie W
    Oxid Med Cell Longev; 2020; 2020():7805393. PubMed ID: 32256962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of Fluorescence Sensitization Method for Hydroxysafflor Yellow A.
    Haiyan C; Xiude Q; Chen L; Xinzhe Z; Yuhui MA; Jingna Z; Yu L; Shaoqin GE; Guowei Z; Hailiang N
    Evid Based Complement Alternat Med; 2020; 2020():3027843. PubMed ID: 32419799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxysafflor yellow A exerts neuroprotective effects in cerebral ischemia reperfusion-injured mice by suppressing the innate immune TLR4-inducing pathway.
    Lv Y; Qian Y; Fu L; Chen X; Zhong H; Wei X
    Eur J Pharmacol; 2015 Dec; 769():324-32. PubMed ID: 26607471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hydroxysafflor yellow A on the activity and mRNA expression of four CYP isozymes in rats.
    Xu RA; Xu ZS; Ge RS
    J Ethnopharmacol; 2014 Feb; 151(3):1141-1146. PubMed ID: 24373810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of deferoxamine and hydroxysafflor yellow A to accelerate diabetic wound healing via enhanced angiogenesis.
    Gao SQ; Chang C; Li JJ; Li Y; Niu XQ; Zhang DP; Li LJ; Gao JQ
    Drug Deliv; 2018 Nov; 25(1):1779-1789. PubMed ID: 30338719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxysafflor Yellow A (HSYA) Improves Learning and Memory in Cerebral Ischemia Reperfusion-Injured Rats via Recovering Synaptic Plasticity in the Hippocampus.
    Yu L; Duan Y; Zhao Z; He W; Xia M; Zhang Q; Cao X
    Front Cell Neurosci; 2018; 12():371. PubMed ID: 30405354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated metabolomics and network pharmacology to reveal the mechanisms of hydroxysafflor yellow A against acute traumatic brain injury.
    Li T; Zhang W; Hu E; Sun Z; Li P; Yu Z; Zhu X; Zheng F; Xing Z; Xia Z; He F; Luo J; Tang T; Wang Y
    Comput Struct Biotechnol J; 2021; 19():1002-1013. PubMed ID: 33613866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.